Drug Approval | October 04, 2024
Shilpa Pharma Lifesciences receives CEP from EDQM for API, Desmopressin
This is used to treat central diabetes insipidus and bedwetting
This is used to treat central diabetes insipidus and bedwetting
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The academy has secured partnerships with 15 esteemed hospitals
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
Breakthrough Therapy designation for pain associated with DPN granted by FDA
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Evinova will operate as a separate health-tech business within AstraZeneca
Subscribe To Our Newsletter & Stay Updated
